Close

CRISPR Therapeutics (CRSP), Intellia Therapeutics (NTLA), Caribou Biosciences, and ERS Genomics Enter Global License Agreement

December 16, 2016 8:05 AM EST Send to a Friend
CRISPR Therapeutics (NASDAQ: CRSP), Intellia Therapeutics (NASDAQ: NTLA), Caribou Biosciences, and ERS Genomics announced that the companies and their licensors ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login